He Wei-Wu
- SEC CIK
- 0001542073
No open-market purchases or sales filed in the past year.
Current role at each company
- CASI CASI Pharmaceuticals, Inc (DE)Chairman and CEOas of Jun 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists He Wei-Wu as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2022 (view filing) | Jun 13-15 | 4 daysLate | He Wei-WuChairman and CEO | PPurchase | +88.2K | $3.09 | +$272.5K | +15.8%644.6K after | 3 lots |
| Nov 19, 2021 (view filing) | Nov 17-18 | 2 days | He Wei-WuChairman and CEO | PPurchase | +400.0K | $0.985 | +$394.0K | +7.8%5.56M after | 2 lots |
| Aug 20, 2021 (view filing) | Aug 18-19 | 2 days | He Wei-WuChairman and CEO | PPurchase | +480.0K | $1.28 | +$613.8K | +10.2%5.16M after | 2 lots |